{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:07:47Z","timestamp":1779192467415,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006507","name":"Fundacao Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clim.2026.110711","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:11:23Z","timestamp":1777993883000},"page":"110711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inherited IFNAR1 structural deficiency in severe adverse events following yellow fever vaccination"],"prefix":"10.1016","volume":"285","author":[{"given":"Tamiris","family":"Azamor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Bastard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Marques Vieira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas de Almeida","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenno dos Santos","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Jouanguy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana Gil","family":"Melga\u00e7o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe Soares","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenna Carvalho","family":"da Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana Neves","family":"Tubar\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Prado","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna Nunes da Silva","family":"Agonigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila Dias","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata Saraiva","family":"Pedro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalia dos Santos","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda de Moura","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleska Dias","family":"Schwarcz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterini Sim\u00f5es","family":"Goudouris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennyson Leandro Mathias","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otavio","family":"Cabral-Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia Mouta Nunes","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria de Lourdes de Sousa","family":"Maia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zilton","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula Dinis","family":"Ano Bom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2026.110711_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001638","article-title":"Yellow fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data","volume":"11","author":"Garske","year":"2014","journal-title":"PLoS Med."},{"key":"10.1016\/j.clim.2026.110711_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40794-020-0101-0","article-title":"Yellow fever control: current epidemiology and vaccination strategies","volume":"6","author":"Chen","year":"2020","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"10.1016\/j.clim.2026.110711_bb0015","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1080\/21645515.2015.1022700","article-title":"Serious adverse events associated with yellow fever vaccine","volume":"11","author":"de Menezes Martins","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.clim.2026.110711_bb0020","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1016\/j.vaccine.2014.08.051","article-title":"Risk groups for yellow fever vaccine-associated viscerotropic disease (YEL-AVD)","volume":"32","author":"Seligman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2026.110711_bb0025","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taw045","article-title":"Adverse event reports following yellow fever vaccination, 2007\u201313","volume":"23","author":"Lindsey","year":"2016","journal-title":"J. Travel Med."},{"key":"10.1016\/j.clim.2026.110711_bb0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2026.110711_bb0035","author":"PAHO"},{"key":"10.1016\/j.clim.2026.110711_bb0040","author":"WHO"},{"key":"10.1016\/j.clim.2026.110711_bb0045","author":"WHO"},{"key":"10.1016\/j.clim.2026.110711_bb0050","author":"Minist\u00e9rio da Sa\u00fade do Brasil"},{"key":"10.1016\/j.clim.2026.110711_bb0055","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology","volume":"9","author":"Pulendran","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2026.110711_bb0060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bjid.2018.10.128","article-title":"EVENTOS ADVERSOS P\u00d3S-VACINA\u00c7\u00c3O DE FEBRE AMARELA","volume":"22","author":"Coutinho","year":"2018","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.clim.2026.110711_bb0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/viro.2001.1168","article-title":"Phenotypic and molecular analyses of Yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil","volume":"290","author":"Galler","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.clim.2026.110711_bb0070","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1016\/j.vaccine.2007.04.060","article-title":"Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"25","author":"Sejvar","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2026.110711_bb0075","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1016\/j.vaccine.2012.04.067","article-title":"Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data","volume":"30","author":"Gershman","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2026.110711_bb0080","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.provac.2010.07.012","article-title":"Yellow fever vaccine post-marketing surveillance in Brazil","volume":"2","author":"Martins","year":"2010","journal-title":"Procedia Vaccinol."},{"key":"10.1016\/j.clim.2026.110711_bb0085","doi-asserted-by":"crossref","DOI":"10.5123\/S1679-49742020000100017","article-title":"Fatores associados \u00e0 gravidade dos eventos adversos p\u00f3s-vacina\u00e7\u00e3o contra a febre amarela durante o maior surto da doen\u00e7a registrado no Brasil, 2016-2017","volume":"29","author":"Lucena","year":"2020","journal-title":"Epidemiologia e Servi\u00e7os de Sa\u00fade"},{"key":"10.1016\/j.clim.2026.110711_bb0090","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1084\/jem.20182295","article-title":"Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines","volume":"216","author":"Hernandez","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2026.110711_bb0095","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202486","article-title":"Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine","volume":"218","author":"Bastard","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2026.110711_bb0100","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taad160","article-title":"Yellow fever vaccine-associated neurologic and viscerotropic disease: a 10-year case series of the French National Reference Center for arboviruses with clinical and immunological insights","volume":"31","author":"Le Hir","year":"2024","journal-title":"J. Travel Med."},{"key":"10.1016\/j.clim.2026.110711_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022200","article-title":"USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon \u03b1 response","volume":"6","author":"Fran\u00e7ois-Newton","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2026.110711_bb0110","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/s41467-018-04013-1","article-title":"The molecular basis of JAK\/STAT inhibition by SOCS1","volume":"9","author":"Liau","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2026.110711_bb0115","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41564-019-0421-x","article-title":"Decoding type I and III interferon signalling during viral infection","volume":"4","author":"Mesev","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.clim.2026.110711_bb0120","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41562-022-01431-6","article-title":"A systematic literature review to clarify the concept of vaccine hesitancy","volume":"6","author":"Bussink-Voorend","year":"2022","journal-title":"Nat. Hum. Behav."},{"key":"10.1016\/j.clim.2026.110711_bb0125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2026.110711_bb0130","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1086\/590187","article-title":"Case of Yellow Fever vaccine\u2013associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes","volume":"198","author":"Pulendran","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2026.110711_bb0135","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1016\/j.vaccine.2007.08.061","article-title":"Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease","volume":"25","author":"Belsher","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2026.110711_bb0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.gene.2015.09.058","article-title":"The type I interferons: basic concepts and clinical relevance in immune-mediated inflammatory diseases","volume":"576","author":"L\u00f3pez De Padilla","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.clim.2026.110711_bb0145","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.immuni.2006.09.009","article-title":"Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity","volume":"25","author":"Minegishi","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2026.110711_bb0150","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.coi.2012.04.011","article-title":"Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes","volume":"24","author":"Boisson-Dupuis","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2026.110711_bb0155","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1084\/jem.20140280","article-title":"Human TYK2 deficiency: mycobacterial and viral infections without hyper-IgE syndrome","volume":"212","author":"Kreins","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2026.110711_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13992","article-title":"Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection","volume":"7","author":"Eletto","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2026.110711_bb0165","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/jir.2010.0126","article-title":"Systems biology of interferon responses","volume":"31","author":"Hertzog","year":"2011","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.clim.2026.110711_bb0170","doi-asserted-by":"crossref","first-page":"13631","DOI":"10.1073\/pnas.250477397","article-title":"IFN\u03b1\/\u03b2 promotes cell survival by activating NF-\u03baB","volume":"97","author":"Yang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.clim.2026.110711_bb0175","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.immuni.2011.02.006","article-title":"Type I interferon inhibits Interleukin-1 production and inflammasome activation","volume":"34","author":"Guarda","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2026.110711_bb0180","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaci.2024.12.1074","article-title":"Long COVID: pathophysiology, current concepts, and future directions","volume":"155","author":"Skevaki","year":"2025","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2026.110711_bb0185","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20050821","article-title":"Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection","volume":"202","author":"Kolumam","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2026.110711_bb0190","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3201\/eid2903.220989","article-title":"Yellow fever vaccine\u2013associated viscerotropic disease among siblings, S\u00e3o Paulo state, Brazil","volume":"29","author":"Fernandes","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.clim.2026.110711_bb0195","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-201554","article-title":"The CARE guidelines: consensus-based clinical case reporting guideline development","volume":"2013","author":"Gagnier","year":"2013","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.clim.2026.110711_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2023.113568","article-title":"Standardization, validation, and comparative evaluation of a faster and high-performance test for quantification of yellow fever neutralizing antibodies","volume":"522","author":"Sim\u00f5es","year":"2023","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.clim.2026.110711_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-57645-3","article-title":"Comprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1\/5 fractional dose of 17DD-YF primary vaccination in adults","volume":"14","author":"Reis","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2026.110711_bb0210","doi-asserted-by":"crossref","DOI":"10.26717\/BJSTR.2020.25.004271","article-title":"Improvement in throughput and accuracy of neutralization assay results by the automation of image acquisition and analysis","volume":"25","author":"De Lima","year":"2020","journal-title":"BJSTR"},{"key":"10.1016\/j.clim.2026.110711_bb0215","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.clim.2026.110711_bb0220","doi-asserted-by":"crossref","first-page":"eadg7492","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.clim.2026.110711_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/v13010096","article-title":"Activation of an effective immune response after Yellow fever vaccination is associated with the genetic background and early response of IFN-\u03b3 and CLEC5A","volume":"13","author":"Azamor","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.clim.2026.110711_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1456634","article-title":"Immunomodulatory effect of bovine lactoferrin during SARS-CoV-2 infection","volume":"15","author":"Silva","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110711_bb0235","series-title":"nf-core\/rnaseq: nf-core\/rnaseq v3.18.0 - Lithium Lynx","author":"Patel","year":"2024"},{"key":"10.1016\/j.clim.2026.110711_bb0240","doi-asserted-by":"crossref","first-page":"D1040","DOI":"10.1093\/nar\/gks1215","article-title":"INTERFEROME v2.0: an updated database of annotated interferon-regulated genes","volume":"41","author":"Rusinova","year":"2012","journal-title":"Nucleic Acids Res."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661626000495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661626000495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:38:25Z","timestamp":1779190705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661626000495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":48,"alternative-id":["S1521661626000495"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2026.110711","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inherited IFNAR1 structural deficiency in severe adverse events following yellow fever vaccination","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2026.110711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110711"}}